Основная статистика
| CIK | 1825724 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Population Health Investment Co Inc - Class A
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
| February 14, 2023 |
EX-99.B 3 d441376dex99b.htm EX-99.B EXHIBIT B Power of Attorney KNOW ALL MEN BY THESE PRESENTS, that I, Lee S. Ainslie III, hereby make, constitute and appoint Mark Gurevich as my agent and attorney-in -fact for the purpose of executing (i) in my personal capacity or (ii) in my capacity as manager or other officer or representative of Maverick Capital Management, LLC, Maverick Capital, Ltd. or any |
|
| February 14, 2023 |
EX-99.A 2 d441376dex99a.htm EX-99.A EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Class A Ordinary Shares, $0.0001 par value per share of Population Health Investment Co., Inc., dated as of February 14, 2023, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed |
|
| February 14, 2023 |
SC 13G/A 1 d441376dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Population Health Investment Co., Inc. (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) G71716107 (CUSIP Number) December 31, 2022 (Date of Event Which Requires |
|
| January 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 1) POPULATION HEALTH INVESTMENT CO., INC. (Name of Issuer) CLASS A ORDINARY SHARES, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) G71716107 (CUSIP Number) DECEMBER 31, 2022 (Date of event which requires filing of this statement) Check the approp |
|
| December 12, 2022 |
15-12G 1 d429074d1512g.htm 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-39706 Population Health Investment Co |
|
| November 18, 2022 |
EX-99.1 2 d398160dex991.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE: POPULATION HEALTH INVESTMENT CO., INC. WILL REDEEM ITS PUBLIC SHARES AND WILL NOT CONSSUMMATE AN INITIAL BUSINESS COMBINATION New York, NY (November 18, 2022) - Population Health Investment Co., Inc. (Nasdaq: PHIC), a special purpose acquisition company (the “Company”), today announced that it will redeem all of its outstandin |
|
| November 18, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2022 Population Health Investment Co., Inc. (Exact name of registrant as specified in its charter) Cayman Islands 001-39706 98-1556837 (State or other jurisdiction of inc |
|
| November 10, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Population Health Inv |
|
| August 12, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Population Health Investme |
|
| May 16, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Population Health Investm |
|
| April 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 POPULATION HEALTH INVESTMENT CO., INC. (Name of Issuer) CLASS A ORDINARY SHARES, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) G71716107 (CUSIP Number) APRIL 14, 2022 (Date of event which requires filing of this statement) Check the appropriate box to designat |
|
| March 30, 2022 |
Amended and Restated Promissory Note, dated as of January 1, 2022, issued to the Sponsor. * Exhibit 10.1 Population Health Investment Co., Inc. One World Financial Center New York, New York 10281 January 1, 2022 Population Health Investment Holding, Inc. One World Financial Center New York, New York 10281 Re: Second Promissory Note Amendment Population Health Investment Holding, Inc.: Reference is made to that certain Promissory Note in the Principal Amount of up to $300,000 by and betwe |
|
| March 30, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Population Health Investment Co., Inc. (Exac |
|
| February 14, 2022 |
EXHIBIT B Power of Attorney KNOW ALL MEN BY THESE PRESENTS, that I, Lee S. Ainslie III, hereby make, constitute and appoint Mark Gurevich as my agent and attorney-in -fact for the purpose of executing (i) in my personal capacity or (ii) in my capacity as manager or other officer or representative of Maverick Capital Management, LLC, Maverick Capital, Ltd. or any affiliate of either, all documents |
|
| February 14, 2022 |
PHICU / Population Health Investment Co., Inc. Unit / GLAZER CAPITAL, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 Population Health Investment Co Inc (Name of Issuer) Units, each consisting of one Class A ordinary share and one-third of a Warrant to acquire one Class A ordinary share (Title of Class of Securities) G71716123 (CUSIP Number) December 31, 2021 (Date of Event Which Requi |
|
| February 14, 2022 |
EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Class A Ordinary Shares, $0. |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Population Health Investment Co., Inc. (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) G71716107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the app |
|
| February 11, 2022 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b) (Amendment No. 1)* Population Health Investment Co., Inc. (Name of Issuer) Class A Ordinary Shares, par value $0.0001 (Title of Class of Securities) G71716123 (CUSIP Number) D |
|
| February 2, 2022 |
SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* POPULATION HEALTH INVESTMENT CO., INC. (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) G71716107 (CUSIP Number) January 24, 2022 (Date of Event Which Requires Filing of this Statement) Check the |
|
| January 7, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 2) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Population Health Invest |
|
| January 7, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to P |
|
| December 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2021 Population Health Investment Co., Inc. (Exact name of registrant as specified in its charter) Cayman Islands 001-39706 98-1556837 (State or other jurisdiction of inc |
|
| November 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Population Health Inv |
|
| August 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Population Health Investment Co., Inc. (Exac |
|
| May 24, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Population Health Investm |
|
| May 19, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Population Health Invest |
|
| May 17, 2021 |
OMB APPROVAL OMB Number: 3235-0058 Estimated average burden hours per response 2.50 SEC FILE NUMBER 001-39706 CUSIP NUMBER G71716123 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-CEN ? Form N-CSR For Period Ended: March 31, 2021 ? Transition Report on |
|
| May 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2021 Population Health Investment Co., Inc. (Exact name of registrant as specified in its charter) Cayman Islands 001-39706 98-1556837 (State or other jurisdiction of incorpor |
|
| March 31, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Population Health Investment Co., Inc. (Exac |
|
| March 31, 2021 |
Indemnification Agreement, dated as of November 17, 2020, between the Company and Clarke Futch Exhibit 10.8 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the ?Agreement?) is made and entered into as of November 17, 2020 between Population Health Investment Co., Inc., a Cayman Islands exempted company (the ?Company?), and Clarke Futch (?Indemnitee?). WITNESSETH THAT: WHEREAS, highly competent persons have become more reluctant to serve companies and corporations as directors or i |
|
| March 31, 2021 |
Exhibit 10.13 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the ?Agreement?) is made and entered into as of November 18, 2020 between Population Health Investment Co., Inc., a Cayman Islands exempted company (the ?Company?), and Christopher Visioli (?Indemnitee?). WITNESSETH THAT: WHEREAS, highly competent persons have become more reluctant to serve companies and corporations as direct |
|
| March 31, 2021 |
Indemnification Agreement, dated as of November 17, 2020, between the Company and Charles Homcy Exhibit 10.9 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the ?Agreement?) is made and entered into as of November 17, 2020 between Population Health Investment Co., Inc., a Cayman Islands exempted company (the ?Company?), and Charles Homcy (?Indemnitee?). WITNESSETH THAT: WHEREAS, highly competent persons have become more reluctant to serve companies and corporations as directors or |
|
| March 31, 2021 |
Indemnification Agreement, dated as of November 18, 2020, between the Company and Christopher Cox. Exhibit 10.12 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the ?Agreement?) is made and entered into as of November 18, 2020 between Population Health Investment Co., Inc., a Cayman Islands exempted company (the ?Company?), and Christopher Cox (?Indemnitee?). WITNESSETH THAT: WHEREAS, highly competent persons have become more reluctant to serve companies and corporations as directors |
|
| March 31, 2021 |
Indemnification Agreement, dated as of November 17, 2020, between the Company and Farah Champsi. Exhibit 10.11 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the ?Agreement?) is made and entered into as of November 17, 2020 between Population Health Investment Co., Inc., a Cayman Islands exempted company (the ?Company?), and Farah Champsi (?Indemnitee?). WITNESSETH THAT: WHEREAS, highly competent persons have become more reluctant to serve companies and corporations as directors or |
|
| March 31, 2021 |
Indemnification Agreement, dated as of November 17, 2020, between the Company and Ian Read. Exhibit 10.10 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the ?Agreement?) is made and entered into as of November 17, 2020 between Population Health Investment Co., Inc., a Cayman Islands exempted company (the ?Company?), and Ian Read (?Indemnitee?). WITNESSETH THAT: WHEREAS, highly competent persons have become more reluctant to serve companies and corporations as directors or in o |
|
| March 31, 2021 |
Indemnification Agreement, dated as of November 18, 2020, between the Company and Whit Bernard. Exhibit 10.14 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the ?Agreement?) is made and entered into as of November 18, 2020 between Population Health Investment Co., Inc., a Cayman Islands exempted company (the ?Company?), and Whit Bernard (?Indemnitee?). WITNESSETH THAT: WHEREAS, highly competent persons have become more reluctant to serve companies and corporations as directors or |
|
| March 31, 2021 |
Indemnification Agreement, dated as of November 17, 2020, between the Company and Clive Meanwell. Exhibit 10.7 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the ?Agreement?) is made and entered into as of November 17, 2020 between Population Health Investment Co., Inc., a Cayman Islands exempted company (the ?Company?), and Clive Meanwell (?Indemnitee?). WITNESSETH THAT: WHEREAS, highly competent persons have become more reluctant to serve companies and corporations as directors or |
|
| March 31, 2021 |
Exhibit 4.4 DESCRIPTION OF SECURITIES We are a Cayman Islands exempted company and our affairs are governed by our amended and restated memorandum and articles of association, the Companies Law and the common law of the Cayman Islands. Pursuant to our amended and restated memorandum and articles of association, we are authorized to issue 300,000,000 Class A ordinary shares and 30,000,000 Class B o |
|
| February 16, 2021 |
SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Population Health Investment Co., Inc. (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) G71716123** (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check t |
|
| February 16, 2021 |
Population Health Investment Co Inc SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Population Health Investment Co Inc (Name of Issuer) Class A ordinary share, par value $0.0001 per share (Title of Class of Securities) G71716123 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule purs |
|
| February 16, 2021 |
Exhibit B Power of Attorney KNOW ALL MEN BY THESE PRESENTS, that I, Lee S. Ainslie III, hereby make, constitute and appoint Mark Gurevich as my agent and attorney-in -fact for the purpose of executing (i) in my personal capacity or (ii) in my capacity as manager or other officer or representative of Maverick Capital Management, LLC, Maverick Capital, Ltd. or any affiliate of either, all documents |
|
| February 16, 2021 |
Exhibit C Power of Attorney KNOW ALL MEN BY THESE PRESENTS, that I, Andrew H. Warford, hereby make, constitute and appoint Mark Gurevich as my agent and attorney-in-fact for the purpose of executing (i) in my personal capacity or (ii) in my capacity as manager or other officer or representative of Maverick Capital, Ltd. or any affiliate of either, all documents to be filed with or delivered to any |
|
| February 16, 2021 |
EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Class A Ordinary Shares, $0. |
|
| January 5, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2021 Population Health Investment Co., Inc. (Exact name of registrant as specified in its charter) Cayman Islands 001-39706 98-1556837 (State or other jurisdiction of incor |
|
| January 5, 2021 |
EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE: POPULATION HEALTH INVESTMENT CO., INC. ANNOUNCES THE SEPARATE TRADING OF ITS CLASS A ORDINARY SHARES AND WARRANTS, COMMENCING ON OR ABOUT JANUARY 8, 2021 New York, NY (January 5, 2021) – Population Health Investment Co., Inc. (the “Company”) announced today that holders of the units sold in the Company’s initial public offering of 17,250,000 units comple |
|
| November 27, 2020 |
Financial Statements and Exhibits, Other Events - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2020 Population Health Investment Co., Inc. (Exact name of registrant as specified in its charter) Cayman Islands 001-39706 98-1556837 (State or other jurisdiction of |
|
| November 27, 2020 |
EX-99.1 Exhibit 99.1 POPULATION HEALTH INVESTMENT CO., INC. Report of Independent Registered Public Accounting Firm F-2 Balance Sheet F-3 Notes to Financial Statement F-4 Report of Independent Registered Public Accounting Firm To the Shareholders and the Board of Directors of Population Health Investment Co., Inc. Opinion on the Financial Statement We have audited the accompanying balance sheet of |
|
| November 25, 2020 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b) (Amendment No. )* Population Health Investment Co., Inc. (Name of Issuer) Class A Ordinary Shares, par value $0.0001 (Title of Class of Securities) G71716123 (CUSIP Number) No |
|
| November 20, 2020 |
EX-4.1 Exhibit 4.1 WARRANT AGREEMENT POPULATION HEALTH INVESTMENT CO., INC. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY Dated November 17, 2020 THIS WARRANT AGREEMENT (this “Agreement”), dated November 17, 2020, is by and between Population Health Investment Co., Inc., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as w |
|
| November 20, 2020 |
Population Health Announces Pricing Of $150 Million Initial Public Offering EX-99.1 Exhibit 99.1 Population Health Announces Pricing Of $150 Million Initial Public Offering NEW YORK, Nov. 18, 2020 /PRNewswire/ — Population Health Investment Co., Inc. (Nasdaq: PHICU, the “Company”) announced today the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Capital Market (“Nasdaq”) and trade under the |
|
| November 20, 2020 |
Amended and Restated Memorandum and Articles of Association. EX-3.1 Exhibit 3.1 POPULATION HEALTH INVESTMENT CO., INC. (THE “COMPANY”) WRITTEN SHAREHOLDER RESOLUTIONS OF THE COMPANY MADE ON 16 NOVEMBER 2020 The undersigned, being the sole Shareholder of the Company having the right to receive notice of, attend and vote at general meetings hereby resolves the following shareholder resolution. 1. REPLACE EXISTING MEMORANDUM & ARTICLES OF ASSOCIATION 1.1 IT IS |
|
| November 20, 2020 |
EX-10.2 Exhibit 10.2 REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT THIS REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT (this “Agreement”), dated as of November 17, 2020, is made and entered into by and among Population Health Investment Co., Inc., a Cayman Islands exempted company (the “Company”), Population Health Investment Holding, Inc., a Cayman Islands exempted company (the “Sponsor”, and toge |
|
| November 20, 2020 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2020 Population Health Investment Co., Inc. (Exact name of registrant as specified in its charter) Cayman Islands 001-39706 98-1556837 (State or other jurisdiction of |
|
| November 20, 2020 |
EX-10.3 Exhibit 10.3 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of November 17, 2020 (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), is entered into by and among Population Health Investment Co., Inc., a Cayman Islands exempted company (the “Company”) and Population Health Inves |
|
| November 20, 2020 |
EX-10.1 Exhibit 10.1 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of November 17, 2020 by and between Population Health Investment Co., Inc., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Company’s registration stateme |
|
| November 20, 2020 |
EX-1.1 Exhibit 1.1 POPULATION HEALTH INVESTMENT CO., INC. 15,000,000 Units UNDERWRITING AGREEMENT November 17, 2020 J.P. Morgan Securities LLC As Representative of the several Underwriters listed in Schedule 1 hereto c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 Ladies and Gentlemen: Population Health Investment Co., Inc., a Cayman Islands corporation (the “Company”), |
|
| November 20, 2020 |
EX-10.4 Exhibit 10.4 November 17, 2020 Population Health Investment Co., Inc. One World Financial Center New York, New York 10281 Re: Initial Public Offering Ladies and Gentlemen: This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among Population Health Investment Co., Inc., a Cayman Isla |
|
| November 19, 2020 |
15,000,000 units Population Health Investment Co., Inc. Book-running manager J.P. Morgan Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-249756 Prospectus $150,000,000 Population Health Investment Co., Inc. 15,000,000 units Population Health Investment Co., Inc. is a newly incorporated blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, r |
|
| November 16, 2020 |
8-A12B 1 d28960d8a12b.htm 8-A12B U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Population Health Investment Co., Inc. (Exact Name of Registrant as Specified in Its Charter) Cayman Islands 98-1556837 (State of Incorporation or Organization) (I.R.S. Em |
|
| November 12, 2020 |
Form of Underwriting Agreement. EX-1.1 Exhibit 1.1 POPULATION HEALTH INVESTMENT CO., INC. 15,000,000 Units UNDERWRITING AGREEMENT [●], 2020 J.P. Morgan Securities LLC As Representative of the several Underwriters listed in Schedule 1 hereto c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 Ladies and Gentlemen: Population Health Investment Co., Inc., a Cayman Islands corporation (the “Company”), proposes |
|
| November 12, 2020 |
Form of Nominating Committee Charter EX-99.7 Exhibit 99.7 POPULATION HEALTH INVESTMENT CO., INC. Nominating Committee Charter I. General Statement of Purpose The Nominating Committee (the “Nominating Committee”) of the Board of Directors (the “Board”) of Population Health Investment Co., Inc. (the “Company”) is responsible for identifying individuals qualified to become board members, consistent with criteria approved by the Board, w |
|
| November 12, 2020 |
Form of Compensation Committee Charter EX-99.6 Exhibit 99.6 POPULATION HEALTH INVESTMENT CO., INC. Compensation Committee Charter I. General Statement of Purpose The Compensation Committee of the Board of Directors (the “Compensation Committee”) of Population Health Investment Co., Inc. (the “Company”), on behalf of the Board of Directors (the “Board”), discharges the Board’s responsibilities relating to compensation of the Company’s d |
|
| November 12, 2020 |
S-1/A Table of Contents As filed with the U.S. Securities and Exchange Commission on November 12, 2020. Registration No. 333-249756 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Population Health Investment Co., Inc. (Exact name of registrant as specified in its charter) Cayman Islands 677 |
|
| November 12, 2020 |
EX-99.4 Exhibit 99.4 CONSENT OF CHARLES HOMCY Population Health Investment Co., Inc. (the “Company”) intends to file a Registration Statement on Form S-1 (together with any amendments or supplements thereto, the “Registration Statement”) registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby c |
|
| November 12, 2020 |
Form of Audit Committee Charter EX-99.5 Exhibit 99.5 POPULATION HEALTH INVESTMENT CO., INC. Audit Committee Charter I. General Statement of Purpose The purposes of the Audit Committee of the Board of Directors (the “Audit Committee”) of Population Health Investment Co., Inc. (the “Company”) are to: • oversee the accounting and financial reporting processes of the Company and the audits of the Company’s financial statements; • ov |
|
| November 12, 2020 |
EX-99.1 Exhibit 99.1 CONSENT OF IAN READ Population Health Investment Co., Inc. (the “Company”) intends to file a Registration Statement on Form S-1 (together with any amendments or supplements thereto, the “Registration Statement”) registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consen |
|
| November 12, 2020 |
Code of Business Conduct and Ethics. EX-14.1 Exhibit 14.1 POPULATION HEALTH INVESTMENT CO., INC. Code of Business Conduct and Ethics Introduction Purpose and Scope The Board of Directors (the “Board of Directors”) of Population Health Investment Co., Inc. (the “Company”) established this Code of Business Conduct and Ethics to aid the Company’s directors, officers, employees and certain designated agents in making ethical and legal de |
|
| November 12, 2020 |
Form of Amended and Restated Memorandum and Articles of Association. EX-3.2 Exhibit 3.2 THE COMPANIES LAW (AS AMENDED) COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF POPULATION HEALTH INVESTMENT CO., INC. (ADOPTED BY SPECIAL RESOLUTION DATED [●], 2020) 1. The name of the company is Population Health Investment Co., Inc. (the “Company”). 2. The registered office of the Company will be situated at the offices of Walkers Corporate Limited, |
|
| November 12, 2020 |
EX-99.2 Exhibit 99.2 CONSENT OF FARAH CHAMPSI Population Health Investment Co., Inc. (the “Company”) intends to file a Registration Statement on Form S-1 (together with any amendments or supplements thereto, the “Registration Statement”) registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby c |
|
| November 12, 2020 |
EX-99.3 Exhibit 99.3 CONSENT OF CLARKE FUTCH Population Health Investment Co., Inc. (the “Company”) intends to file a Registration Statement on Form S-1 (together with any amendments or supplements thereto, the “Registration Statement”) registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby co |
|
| October 30, 2020 |
Promissory Note, dated as of September 17, 2020, issued to the Sponsor. EX-10.5 Exhibit 10.5 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE |
|
| October 30, 2020 |
Form of Specimen Warrant Certificate. EX-4.3 Exhibit 4.3 [FACE] Number Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW Population Health Investment Co., Inc. Incorporated Under the Laws of the Cayman Islands CUSIP G71716 115 Warrant Certificate This Warrant Certificate certifies that [●], or registered assigns, is the registered h |
|
| October 30, 2020 |
Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant. EX-4.4 Exhibit 4.4 WARRANT AGREEMENT POPULATION HEALTH INVESTMENT CO., INC. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY Dated [●], 2020 THIS WARRANT AGREEMENT (this “Agreement”), dated [●], 2020, is by and between Population Health Investment Co., Inc., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in |
|
| October 30, 2020 |
S-1 Table of Contents As filed with the U.S. Securities and Exchange Commission on October 30, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Population Health Investment Co., Inc. (Exact name of registrant as specified in its charter) Cayman Islands 6770 98-1556837 (State or Other |
|
| October 30, 2020 |
Form of Amended and Restated Memorandum and Articles of Association. EX-3.2 Exhibit 3.2 THE COMPANIES LAW (AS AMENDED) COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF POPULATION HEALTH INVESTMENT CO., INC. (ADOPTED BY SPECIAL RESOLUTION DATED [●], 2020) 1. The name of the company is Population Health Investment Co., Inc. (the “Company”). 2. The registered office of the Company will be situated at the offices of Walkers Corporate Limited, |
|
| October 30, 2020 |
EX-10.1 Exhibit 10.1 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of [●], 2020 by and between Population Health Investment Co., Inc., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Company’s registration statement on Fo |
|
| October 30, 2020 |
Memorandum and Articles of Association. EX-3.1 Exhibit 3.1 THE COMPANIES LAW (AS AMENDED) COMPANY LIMITED BY SHARES MEMORANDUM OF ASSOCIATION OF POPULATION HEALTH INVESTMENT CO., INC. 1. The name of the company is Population Health Investment Co., Inc. (the “Company”). 2. The registered office of the Company will be situated at the offices of Walkers Corporate Limited, Cayman Corporate Centre, 27 Hospital Road, George Town, Grand Cayman |
|
| October 30, 2020 |
EX-10.2 Exhibit 10.2 REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT THIS REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT (this “Agreement”), dated as of [●], 2020, is made and entered into by and among Population Health Investment Co., Inc., a Cayman Islands exempted company (the “Company”), Population Health Investment Holding, Inc., a Cayman Islands exempted company (the “Sponsor”, and together wit |
|
| October 30, 2020 |
Form of Specimen Unit Certificate. EX-4.1 Exhibit 4.1 SPECIMEN UNIT CERTIFICATE NUMBER UNITS U-[●] Population Health Investment Co., Inc. CUSIP G71716 123 UNITS CONSISTING OF ONE CLASS A ORDINARY SHARE AND ONE-THIRD OF ONE REDEEMABLE WARRANT TO PURCHASE ONE CLASS A ORDINARY SHARE THIS CERTIFIES THAT [●] is the owner of Units. Each Unit (“Unit”) consists of one (1) Class A ordinary share, par value $0.0001 per share (“Ordinary Share |
|
| October 30, 2020 |
EX-10.4 Exhibit 10.4 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of [●], 2020 between Population Health Investment Co., Inc., a Cayman Islands exempted company (the “Company”), and [●] (“Indemnitee”). WITNESSETH THAT: WHEREAS, highly competent persons have become more reluctant to serve companies and corporations as directors or in other c |
|
| October 30, 2020 |
Form of Private Placement Warrant Agreement between the Registrant and the Sponsor. EX-10.3 Exhibit 10.3 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of [●], 2020 (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), is entered into by and among Population Health Investment Co., Inc., a Cayman Islands exempted company (the “Company”) and Population Health Investment Ho |
|
| October 30, 2020 |
EX-10.7 Exhibit 10.7 [●], 2020 Population Health Investment Co., Inc. One World Financial Center New York, New York 10281 Re: Initial Public Offering Ladies and Gentlemen: This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among Population Health Investment Co., Inc., a Cayman Islands exem |
|
| October 30, 2020 |
Form of Specimen Ordinary Share Certificate. EX-4.2 Exhibit 4.2 SPECIMEN CLASS A ORDINARY SHARE CERTIFICATE NUMBER SHARES POPULATION HEALTH INVESTMENT CO., INC. INCORPORATED UNDER THE LAWS OF THE CAYMAN ISLANDS CLASS A ORDINARY SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP G71716 107 This certifies that is the owner of FULLY PAID AND NON-ASSESSABLE CLASS A ORDINARY SHARES OF THE PAR VALUE OF US $0.0001 EACH OF POPULATION HEALTH INVESTMENT |
|
| October 30, 2020 |
EX-10.6 Exhibit 10.6 Population Health Investment Co., Inc. One World Financial Center New York, New York 10281 September 17, 2020 Population Health Investment Holding, Inc. One World Financial Center New York, New York 10281 Re: Securities Subscription Agreement Gentlemen: This agreement (this “Agreement”) is entered into on September 17, 2020 by and between Population Health Investment Holding, |
|
| September 24, 2020 |
DRS Table of Contents As confidentially submitted to the U.S. Securities and Exchange Commission on September 23, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Population Health Investment Co., Inc. (Exact name of registrant as specified in its charter) Cayman Islands 6770 98-1556 |
